David Roesti Novartis Pharma Stein AG

Dr. David Roesti holds a PhD in microbial ecology from the University of Neuchâtel, Switzerland and has more than 25 years of experience in the field of microbiology. Currently he works at Novartis Pharma AG in Stein Switzerland in the Manufacturing Science & Technology department and is responsible to define the microbial control strategy at the site and is a global subject matter expert in microbiology for the Novartis group. Prior to this assignment, he led the Rapid Microbiological Methods team at Novartis Pharma AG and was the laboratory supervisor for the microbiological testing of non-sterile drug products at Novartis Pharma Stein AG. David Roesti is an elected member of the General Chapters Microbiology Expert Committee of the United States Pharmacopoeia 2022-2025 revision cycle and is a member of the advisory board of the European Compliance Academy Microbiology Group. Finally, David Roesti is main author or co-author of many different publications in either peer-reviewed journals or book chapters and has regularly held presentations in scientific congresses or expert groups.